Company news

Microbix Biosystems Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Microbix Reviews New U.S. Tariffs on Canada

October 28, 2026

Microbix Presenting at Planet MicroCap Investment Conference

October 26, 2026

Microbix Attending & Presenting at IPVS 2026

October 19, 2026

Microbix Making Keynote Presentation at Masters Summit 2026

October 8, 2026

Microbix Presenting at Cantech Investment Conference

October 6, 2026

Microbix Qualifies as Supplier for Five Major Dx Test-Makers Product Lines for Support of Leading IVD Manufacturers

September 9, 2026

Microbix Reports Results for Q3 Fiscal 2026

August 13, 2026

Microbix Schedules Release of Results for Q3 Fiscal 2026

August 6, 2026

Microbix Reports Results for H1 & Q2 2026

May 14, 2026

Microbix Schedules Release of Results for Q2 Fiscal 2026

May 7, 2026

Microbix Product Results Being Presented at 2026 PASCV

April 27, 2026

Microbix Engages with Diagnostics Industry Experts

April 20, 2026

Microbix Presenting at the 2026 Bloom Burton Conference

April 16, 2026

Microbix Exhibiting & Presenting at ESCMID Global 2026

April 15, 2026

Microbix Announces Annual Meeting Voting Results

March 26, 2026

Microbix Presents Reference-Material Innovations at EUROGIN

March 17, 2026

Microbix Reports Results for Q1 2026

February 12, 2026

Microbix Welcomes The College of American Pathologists as a Client For Supply of QAPs for PT/EQA Programs

February 10, 2026

Microbix Schedules Release of Results for Q1 Fiscal 2026

February 5, 2026

Microbix Presents Molecular Pathology Platform Results

February 4, 2026

Microbix Updates Investor Presentation on its Website

January 9, 2026

Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen For Usage in QAPs and Test Manufacturing

January 7, 2026

Microbix Reports Results for Q4 and Fiscal 2025

December 18, 2025

Microbix Schedules Release of Results for Q4 Fiscal 2025

December 11, 2025

Microbix Launches New Products to Support H3N2 Flu Testing

December 10, 2025

Microbix Announces Initiation of Normal Course Issuer Bid

December 4, 2025

Microbix & Seegene Mexico Collaborate to Improve Test Accuracy

December 3, 2025

Microbix Partners with SEKISUI Diagnostics to Support COVID/Flu Tests

November 12, 2025

Microbix Addresses Cybersecurity Incident

November 5, 2025

Microbix Presenting at Muskoka Capital Event

September 25, 2025

Microbix Assisting EMQN with Second Genetic-Test EQA Program

September 23, 2025

Microbix Client Labquality Introduces Novel EQA Scheme at ESCV

September 17, 2025

Microbix Hosts Ontario Minister Stephen Crawford

September 3, 2025

Microbix Reports Results for Q3 Fiscal 2025

August 14, 2025

Microbix Schedules Release of Results for Q3 Fiscal 2025 Results Release and Webinar Discussion on Morning of August 14, 2025

August 7, 2025

Microbix Launches QUANTDx™ Characterized Reference Materials

July 29, 2025

Microbix Exhibiting & Presenting at ADLM

July 24, 2025

Microbix & Bulgaria’s NCIPD Execute Supply Agreement

July 8, 2025

Microbix Attending & Presenting at Asia Pacific POC 2025

June 17, 2025

Microbix Reports Results for Q2 Fiscal 2025

May 15, 2025

Microbix & Aurevia Introduce Novel EQA Scheme

May 13, 2025

Microbix Schedules Release of Results for Q2 Fiscal 2025

May 8, 2025

Microbix’s Clot-Buster Drug Project Advances

May 5, 2025

Microbix Presenting at the 2025 Bloom Burton Conference

May 1, 2025

Microbix Exhibiting at ESCMID Global 2025

April 9, 2025

Microbix Provides Business Updates

April 8, 2025

Microbix Announces Annual and Special Meeting Voting Results

March 27, 2025

Microbix Further Optimizes Capital Usage and Availability

March 26, 2025

Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific

March 17, 2025

Microbix Hosts Ontario Premier Doug Ford & Team

February 27, 2025

Older news releases →

Calls

The 5 newest of 12 calls. Every call is listed under its year.

Decks

The 5 newest of 7 decks. Every deck is listed under its year.